Mar 1, 20223 min read

Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX00

ASHBURN, Va., March 01, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...

Feb 10, 20223 min read

Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX003

ASHBURN, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...

Jan 31, 20222 min read

Istanbul, Turkey – January 31, 2022 – Er-Kim, a regional specialty pharmaceutical company, announced today the signature of an exclusive...

Jun 30, 20214 min read

Er-Kim Announces Exclusive Distribution Agreement and Acceptance of Priority New Drug Application for BTK Inhibitor BRUKINSA®...

Jun 29, 20216 min read

Extends relationship with Er-Kim following Turkey agreement for Alkindi® and Efmody® Diurnal Group plc (AIM: DNL), the specialty...